Search

Your search keyword '"Park, So Hee"' showing total 10,630 results

Search Constraints

Start Over You searched for: Author "Park, So Hee" Remove constraint Author: "Park, So Hee" Database Unpaywall Remove constraint Database: Unpaywall
10,630 results on '"Park, So Hee"'

Search Results

10. Palbociclib plus exemestane with GnRH agonist vs capecitabine in premenopausal patients with HR+/HER2- metastatic breast cancer: Updated survival results of the randomized phase 2 study Young-PEARL.

11. Paraoxonase‐2 agonist vutiglabridin promotes autophagy activation and mitochondrial function to alleviate non‐alcoholic steatohepatitis

15. Combi-Matrix Based on TiO2 Aerogel for Diagnosis of Sepsis Using Laser Desorption and Ionization Mass Spectrometry

19. Nationwide real-world practice pattern and clinical data of palbociclib in patients with HR(+), HER2(-) metastatic breast cancer (KCSG BR21-15).

26. heredERA Breast Cancer: a phase III, randomized, open-label study evaluating the efficacy and safety of giredestrant plus the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with previously untreated HER2-positive, estrogen receptor-positive locally advanced or metastatic breast cancer

32. Outcomes in Nonmetastatic Hormone Receptor–Positive HER2-Negative Pure Mucinous Breast Cancer: A Multicenter Cohort Study

33. A 10-Gene Signature to Predict the Prognosis of Early-Stage Triple-Negative Breast Cancer

34. Efficacy of Integrated Risk Score Using Omics-Based Biomarkers for the Prediction of Acute Rejection in Kidney Transplantation: A Randomized Prospective Pilot Study

35. Antigenic Characterization of Circulating and Emerging SARS-CoV-2 Variants in the U.S. throughout the Delta to Omicron Waves

37. Relationship between high-density lipoprotein cholesterol and mortality in elderly hemodialysis patients: Data from the Korean Society of Geriatric Nephrology Retrospective Cohort

40. Cardioprotective effect of SGLT2 inhibitor in diabetic kidney transplant recipients: A multicenter propensity score matched study

42. Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): patient-reported outcomes from a randomised, open-label, multicentre, phase 3 trial

43. Synergistic Effect of Ferroptosis‐Inducing Nanoparticles and X‐Ray Irradiation Combination Therapy (Small 19/2024)

47. MiR-29 and MiR-140 regulate TRAIL-induced drug tolerance in lung cancer

Catalog

Books, media, physical & digital resources